CVE-2026-32623 Vulnerability Analysis & Exploit Details

CVE-2026-32623
Vulnerability Scoring

8.1
/10
Severe Risk

Cybersecurity professionals consider CVE-2026-32623 an immediate threat requiring urgent mitigation.

Attack Complexity Details

  • Attack Complexity: High
    Exploits require significant effort and special conditions.
  • Attack Vector: Network
    Vulnerability is exploitable over a network without physical access.
  • Privileges Required: None
    No privileges are required for exploitation.
  • Scope: Unchanged
    Exploit remains within the originally vulnerable component.
  • User Interaction: None
    No user interaction is necessary for exploitation.

CVE-2026-32623 Details

Status: Analyzed

Last updated: 🕑 27 Apr 2026, 14:18 UTC
Originally published on: 🕗 17 Apr 2026, 20:16 UTC

Time between publication and last update: 9 days

CVSS Release: version 3

CVSS3 Source

nvd@nist.gov

CVSS3 Type

Primary

CVSS3 Vector

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H

CVE-2026-32623 Vulnerability Summary

CVE-2026-32623: xrdp is an open source RDP server. Versions through 0.10.5 contain a heap-based buffer overflow vulnerability in the NeutrinoRDP module. When proxying RDP sessions from xrdp to another server, the module fails to properly validate the size of reassembled fragmented virtual channel data against its allocated memory buffer. A malicious downstream RDP server (or an attacker capable of performing a Man-in-the-Middle attack) could exploit this flaw to cause memory corruption, potentially leading to a Denial of Service (DoS) or Remote Code Execution (RCE). The NeutrinoRDP module is not built by default. This vulnerability only affects environments where the module has been explicitly compiled and enabled. Users can verify if the module is built by checking for --enable-neutrinordp in the output of the xrdp -v command. This issue has been fixed in version 0.10.6.

Assessing the Risk of CVE-2026-32623

Access Complexity Graph

The exploitability of CVE-2026-32623 depends on two key factors: attack complexity (the level of effort required to execute an exploit) and privileges required (the access level an attacker needs).

Exploitability Analysis for CVE-2026-32623

CVE-2026-32623 presents a challenge to exploit due to its high attack complexity, but the absence of privilege requirements still makes it a viable target for skilled attackers. A thorough security review is advised.

Understanding AC and PR

A lower complexity and fewer privilege requirements make exploitation easier. Security teams should evaluate these aspects to determine the urgency of mitigation strategies, such as patch management and access control policies.

Attack Complexity (AC) measures the difficulty in executing an exploit. A high AC means that specific conditions must be met, making an attack more challenging, while a low AC means the vulnerability can be exploited with minimal effort.

Privileges Required (PR) determine the level of system access necessary for an attack. Vulnerabilities requiring no privileges are more accessible to attackers, whereas high privilege requirements limit exploitation to authorized users with elevated access.

CVSS Score Breakdown Chart

Above is the CVSS Sub-score Breakdown for CVE-2026-32623, illustrating how Base, Impact, and Exploitability factors combine to form the overall severity rating. A higher sub-score typically indicates a more severe or easier-to-exploit vulnerability.

CIA Impact Analysis

Below is the Impact Analysis for CVE-2026-32623, showing how Confidentiality, Integrity, and Availability might be affected if the vulnerability is exploited. Higher values usually signal greater potential damage.

  • Confidentiality: High
    Exploiting CVE-2026-32623 can result in unauthorized access to sensitive data, severely compromising data privacy.
  • Integrity: High
    CVE-2026-32623 could allow unauthorized modifications to data, potentially affecting system reliability and trust.
  • Availability: High
    CVE-2026-32623 can disrupt system operations, potentially causing complete denial of service (DoS).

CVE-2026-32623 References

External References

CWE Common Weakness Enumeration

CWE-122

CAPEC Common Attack Pattern Enumeration and Classification

  • Forced Integer Overflow CAPEC-92 This attack forces an integer variable to go out of range. The integer variable is often used as an offset such as size of memory allocation or similarly. The attacker would typically control the value of such variable and try to get it out of range. For instance the integer in question is incremented past the maximum possible value, it may wrap to become a very small, or negative number, therefore providing a very incorrect value which can lead to unexpected behavior. At worst the attacker can execute arbitrary code.

Vulnerable Configurations

  • cpe:2.3:a:neutrinolabs:xrdp:-:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:-:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.6.0:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.6.0:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.6.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.6.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.6.2:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.6.2:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.8.0:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.8.0:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.2:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.2:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.3:-:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.3:-:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.3.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.3.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.3:rc1:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.3:rc1:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.4:-:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.4:-:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.4.:rc1:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.4.:rc1:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.5:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.5:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.6:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.6:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.7:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.7:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.8:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.8:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.9:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.9:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.10:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.10:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.11:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.11:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.12:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.12:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.13:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.13:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.13.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.13.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.14:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.14:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.15:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.15:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.16:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.16:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.17:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.17:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.18:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.18:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.18.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.18.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.19:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.19:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.20:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.20:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.21:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.21:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.21.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.21.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.22:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.22:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.22.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.22.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.23:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.23:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.23.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.23.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.24:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.24:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.25:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.25:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.25.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.25.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.26:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.26:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.9.27:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.9.27:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.0:-:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.0:-:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.0:beta1:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.0:beta1:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.0:beta2:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.0:beta2:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.0:beta3:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.0:beta3:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.2:-:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.2:-:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.2:rc1:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.2:rc1:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.3:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.3:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.4:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.4:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.4.1:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.4.1:*:*:*:*:*:*:*
  • cpe:2.3:a:neutrinolabs:xrdp:0.10.5:*:*:*:*:*:*:*
    cpe:2.3:a:neutrinolabs:xrdp:0.10.5:*:*:*:*:*:*:*

Protect Your Infrastructure against CVE-2026-32623: Combat Critical CVE Threats

Stay updated with real-time CVE vulnerabilities and take action to secure your systems. Enhance your cybersecurity posture with the latest threat intelligence and mitigation techniques. Develop the skills necessary to defend against CVEs and secure critical infrastructures. Join the top cybersecurity professionals safeguarding today's infrastructures.

Other 5 Recently Published CVEs Vulnerabilities

  • CVE-2026-8290 – A security flaw has been discovered in Open5GS up to 2.7.7. This issue affects the function smf_nsmf_handle_update_data_in_vsmf of the file /src/sm...
  • CVE-2026-8289 – A vulnerability was identified in Open5GS up to 2.7.7. This vulnerability affects the function smf_nsmf_handle_update_data_in_vsmf of the file /src...
  • CVE-2026-4802 – A flaw was found in Cockpit. This vulnerability allows a remote attacker to achieve arbitrary command execution on the host by exploiting unsanitiz...
  • CVE-2026-8288 – A vulnerability was determined in Open5GS up to 2.7.7. This affects the function gsm_handle_pdu_session_modification_qos_flow_descriptions of the f...
  • CVE-2025-9973 – Due to not validating the organization context when executing adaptive authentication flows, the WSO2 Identity Server allows adaptive authenticatio...